Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Filtrar resultados de búsqueda
Seleccionar modelos de datos

Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

3 Resultados de la búsqueda.

Pulmonary Function Week 38 Mepolizumab HES NCT00086658 - Pulmonary Function Week 38

- 15/7/17 - 1 formulario, 1 itemgroup, 6 items, 1 idioma

Itemgroup: Pulmonary Function Tests

Study part: Pulmonary Function Week 38/ Early Withdrawal visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pulmonary Function Tests Week 16 Mepolizumab HES NCT00086658 - Pulmonary Function Tests Week 16

- 12/7/17 - 1 formulario, 1 itemgroup, 6 items, 1 idioma

Itemgroup: Pulmonary Function Tests

Study part: Pulmonary Function Tests Week 16.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pulmonary Function Tests Day 1 Pre-Infusion Mepolizumab HES NCT00086658 - Pulmonary Function Tests Day 1 Pre-Infusion

- 11/6/17 - 1 formulario, 1 itemgroup, 6 items, 1 idioma

Itemgroup: Pulmonary Function Tests

Study part: Pulmonary Function Tests Day 1 Pre-Infusion.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Utilice este formulario para comentarios, preguntas y sugerencias.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.